Auxly Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Outlook for 2022
TORONTO, March 31, 2022 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX: CBWTF) ("Auxly" or the "Company"),...
Day: March 31, 2022
OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples
BETHLEHEM, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home...
Renalytix announces a $30.0 million financing package
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA,...
Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates
WARRINGTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple...
Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group
CHESTERBROOK, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and...
Amryt Supports World Lipodystrophy Day – March 31, 2022
Amryt Supports World Lipodystrophy Day - March 31, 2022 DUBLIN, Ireland, and Boston MA, March 31, 2022, Amryt (Nasdaq: AMYT), a...
ObsEva Annual Report 2021
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland and Boston, MA – March 31, 2022 – ObsEva SA (NASDAQ:...
BioNTech Announces ADS Repurchase Program
MAINZ, Germany, March 31, 2022 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) today announced that it...
XORTX Files IND with US FDA
● Autosomal Dominant Polycystic Kidney Disease – XRx-008 Program IND Filed ● CALGARY, Alberta, March 31, 2022 (GLOBE NEWSWIRE) -- XORTX...
Delota Acquires $11.13M of Its Own Debt
Vaughan, Ontario--(Newsfile Corp. - March 31, 2022) - Delota Corp. (TSXV: LOTA) ("Delota" or the "Company"), an established Canadian cannabis...
NervGen Presenting Interim Phase 1 Clinical Trial Data for NVG-291 at the 2022 American Academy of Neurology Annual Meeting
Human subjects now being enrolled in the second cohort of multiple ascending dose portion of the studyNVG-291 dose administered in...
VIVO Cannabis Announces Fourth Quarter 2021 Results
Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million.In February 2021, closed a $7.2...
Model N Completes Rainmaker22: Largest Virtual Conference Reporting on the Outlook for Revenue Optimization and Compliance
Leader in Life Sciences and High Tech Revenue Optimization and Compliance Wraps a Successful Thought Leadership Event, Introduces Industry Trends,...
athenahealth Addresses the Needs of Transgender and Gender-Diverse Patients with Improved Gender-Affirming Care Product Functionality
Nearly 200 athenahealth employees participate in company’s first-ever ‘Hack for Health Equity’ and ‘Codefest,’ resulting in gender-affirming care product enhancements...
Cipherome, Inc. Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
American Heart Association consortium advances development of evidence-based health tech solutions SAN JOSE, Calif.--(BUSINESS WIRE)--Cipherome, Inc. (“Cipherome”), a Silicon Valley-based,...
NextGen Healthcare Unveils Latest Solution for Behavioral Health and Human Services
Industry’s First Integrated Care EHR Solution to Support Comprehensive Primary Care and Behavioral Health with Intellectual & Developmental Disabilities (I/DD)...
Thomas H. Lee Partners Acquires Intelligent Medical Objects
Investment will support expanded product development and go-to-market activities ROSEMONT, Ill. & BOSTON--(BUSINESS WIRE)--Thomas H. Lee Partners, L.P. (“THL”), a...
Ivenix to be Acquired by Fresenius Kabi
Transaction Designed to Transform Advanced Infusion Care BOSTON--(BUSINESS WIRE)--#Ivenixinc--Ivenix, Inc. today announced that it has entered into a definitive agreement...
Poolbeg Pharma PLC Announces POLB001 Update – Clinical Trial Agreement Signed
On track to commence LPS human challenge clinical trial in June 2022LONDON, UK / ACCESSWIRE / March 31, 2022 /...
Relief Reports Full-Year 2021 Results and Provides Corporate Update
GENEVA, SWITZERLAND / ACCESSWIRE / March 31, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...